Cholesterol efflux

Biomarker

5 papers study it47 more mention it4 findings

  • Humans2
  • Animals1
  • Cells1

Interventions

1

Urolithin A

upin mouse cells1

1 study
  1. Urolithin A increases cholesterol efflux in mouse cells.

    “UA reduced ox-LDL induced cholesterol accumulation in macrophage cells and promoted cholesterol efflux from cells.”

    Cellsin ox-LDL-treated RAW264.7 cells

    Urolithin A attenuated ox-LDL-induced cholesterol accumulation in macrophages partly through regulating miR-33a and ERK/AMPK/SREBP1 signaling pathways

    Food & function

More on Urolithin A

Upstream

2

Type 2 diabetes

downin humans1

1 study
  1. Type 2 diabetes decreases cholesterol efflux in humans (25.08±1.90 and 29.72±1.75 vs 32.86±2.07).

    “HDL functionality was significantly reduced in T2DM+A (25.08±1.90) and T2DM (29.72±1.75) compared to NGT (32.86±2.07).”

    Humansin T2DM and T2DM with atherosclerosis

    ABC Transporters as Surrogate Biomarkers of HDL Functionality for Early Atherosclerosis Risk Assessment in Type 2 Diabetes Mellitus

    ADA Scientific Sessions 2026 abstract

More on Type 2 diabetes

MIR33

downin mouse cells1

1 study
  1. MIR33 decreases cholesterol efflux in mouse cells.

    “pre-miR-33a attenuated cholesterol efflux induced by UA.”

    Cellsin ox-LDL-treated RAW264.7 cells

    Urolithin A attenuated ox-LDL-induced cholesterol accumulation in macrophages partly through regulating miR-33a and ERK/AMPK/SREBP1 signaling pathways

    Food & function

More on MIR33

Associations

1

ABCA1

upin humans1

1 study
  1. ABCA1 is associated with cholesterol efflux in humans.

    “HDL functionality as measured by CE was significantly reduced in patients with T2DM+A and T2DM, and positively associated with ABC transporters.”

    Humansin T2DM and NGT subjects

    ABC Transporters as Surrogate Biomarkers of HDL Functionality for Early Atherosclerosis Risk Assessment in Type 2 Diabetes Mellitus

    ADA Scientific Sessions 2026 abstract

More on ABCA1

Funding

3 grants since 2020

National Heart, Lung, and Blood InstituteUS$570.5kJapan Society for the Promotion of ScienceJP¥8.5m

Latest

Nov 2025: 1Dec 2025: 2Jan 2026: 2Feb 2026: 0Mar 2026: 2Apr 2026: 0May 2026: 1Jun 2026: 1Jul 2026: 3Aug 2026: 4Sep 2026: 3Oct 2026: 019 papers in 12 months